Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
129,668,560
Number of holders
318
Total 13F shares, excl. options
115,633,668
Shares change
+4,243,700
Total reported value, excl. options
$5,577,437,288
Value change
+$212,796,154
Put/Call ratio
41%
Number of buys
138
Number of sells
-131
Price
$48.24

Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q3 2021

356 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q3 2021.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 318 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 115,633,668 shares of 129,668,560 outstanding shares and own 89.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (18,759,215 shares), VANGUARD GROUP INC (12,670,362 shares), WELLINGTON MANAGEMENT GROUP LLP (7,585,848 shares), Artisan Partners Limited Partnership (6,931,041 shares), JANUS HENDERSON GROUP PLC (4,372,496 shares), Invesco Ltd. (4,007,964 shares), STATE STREET CORP (3,580,742 shares), BROWN ADVISORY INC (3,349,548 shares), AMERIPRISE FINANCIAL INC (2,377,412 shares), and MACQUARIE GROUP LTD (2,042,456 shares).
This table shows the top 318 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.